🔴 Heron Therapeutics is trading 5.3% down today amid rate concerns after hotter-than-expected inflation

Heron Therapeutics is trading 5.25% lower at $0.37, possibly pressured by broader-market weakness after hotter-than-expected September inflation.

• September inflation exceeded expectations, raising concerns about higher interest rates; Reuters reported U.S. stocks were headed lower after the CPI release.
• Major U.S. indices were down more than 0.5%. No new company-specific announcement explaining the October 14 decline was identified.
• Intraday trading volume data was not provided.